Moreover, it has been suggested that α2-AR-mediated signal transduction counterbalances PLC-mediated signaling [99] indicating that cardiac SL α2-ARs may also be an important target [100] and potentially for the mitigation of cardiac hypertrophy. Here, HSPG2 is linked to cardiac hypertrophy.